Podcasts
Join BioPlan Associates as we explore the latest trends, insights, and expert opinions on biopharmaceutical manufacturing.
From Single-use systems, Outsourcing, Capacity constraints, and much more, these podcasts dive into the most pressing issues and emerging opportunities from BioPlan's Annual Report and of Biopharmaceutical Manufacturing Capacity and Production, the most comprehensive, longest-running study of bioprocessing professionals.
October 2026
DCAT: Biomanufacturing: Capacity Trends & CDMO Insights
In the latest episode of DCAT (Drug, Chemical & Associated Technologies Association)’s Production to Prescription podcast, Eric Langer, president and managing partner of BioPlan Associates, breaks down the current state of biomanufacturing drug substance capacity, outsourcing dynamics, and what is really driving the CDMO sector today. Key themes, highlighted from the Annual Report of Biopharmaceutical Manufacturing Capacity and Production, include: Capacity vs. Fit; The Evolution of Outsourcing; Modality Shifts, and Technology & Efficiency Drivers. Full episode hosted by DCAT Value Chain Insights (VCI).
🎧 Listen here: Biomanufacturing: Capacity Trends & CDMO Insights [October 2026]
December 2025
PharmaSource: Biomanufacturing Trends
“If you can’t demonstrate international quality standards, nobody is going to take a chance on a million-dollar batch to save a few dollars on their manufacturing. It just won’t happen.”
Listen here: Biomanufacturing Trends [Dec 2025]
November 2025
BWS Dialogues: Challenges Faced by CDMOs BWS Dialogues Podcast
Eric Langer, president and managing partner of BioPlan Associates, shares his insights — backed by 20 years of data from the Annual Report of Biopharmaceutical Manufacturing Capacity and Production. Eric assesses the particular challenges faced by CDMOs, the role of geopolitics — including changes to H-1B visa rules — and job seekers’ emotional outlook, while putting it all into historical context. Created by Laura Bush, Marketing Director at Bandwidth Solutions.
Listen here: Challenges Faced by CDMOs BWS Dialogues Podcast [November 2025]
April 2025
DCAT: Biomanufacturing: How are Industry Capacity & Supply Chains Trending?
What is industry capacity utilization for biomanufacturing among the major systems/platforms (mammalian, microbial, and advanced therapies, and is there too much capacity or is the market tight? Is biomanufacturing outsourcing up or down? Are biopharma companies outsourcing more or less? Plus the impact on evolving trade policy on biomanufacturing supply chains. Featuring: Eric Langer, MBA, Managing Partner & President, BioPlan Associates and Renaud Jacquemart, PhD, MBA, Senior Advisor, BioPlan Associates. All insights and data backed by data from the Annual Report of Biopharmaceutical Manufacturing Capacity and Production.
Listen here: Biomanufacturing: How are Industry Capacity & Supply Chains Trending? [April 2025]
June 2024
Drug Digest: Changes and Trends in the Outsourcing Landscape [June 2024]
In this episode of Drug Digest, Eric S. Langer, president and managing partner, BioPlan Associates discuss the current outsourcing landscape in the post-COVID world and the changes the pandemic has enforced in the demand for outsourced bioprocessing services. All insights and data backed by data from the Annual Report of Biopharmaceutical Manufacturing Capacity and Production.
🎧 Listen here: Drug Digest: Changes and Trends in the Outsourcing Landscape [June 2024]
2023/2021
Discovery Matters Podcast with CPhI: Industry Surveys and What They Can Tell Us
Dodi Axelson, Discovery Matters Podcast, and Eric Langer, president and managing partner of BioPlan Associates talk about highlights and trends from the Annual Report of Biopharmaceutical Manufacturing Capacity and Production. For this episode of Discovery Matters, key leaders focus on industry surveys and what they can tell us. This includes BioPlan and the Biopharma Resilience Index. Both huge reports providing insight into both the issues and opportunities facing the industry today. Eric Langer, president and managing partner of BioPlan Associates discusses the BioPlan findings and how they echo many of the same themes.
Listen here: Discovery Matters Podcast with CPhI [2023 and 2021]
4-part Educational Series – China’s Emergence in Global Biopharma Manufacturing: Trends in the Chinese Biopharma Series [2019]
This four-part educational series, sponsored by BioProcess International and BioPlan Associates, Inc., highlights key trends emerging in China biopharmaceuticals, using select content from BioPlan Associates’ 2018 2nd edition report, Advances in Biopharmaceutical Technology in China, 2nd Ed., a unique, peer-reviewed study that incorporates the research and work from over 100 global industry expert authors, many based in China.
In Part 1, Michael Frizberg, President, CMAB – Switzerland and Hong Kong, highlights key drivers and areas of growth in China biopharma today, as well as cover areas of opportunities for expansion and revenue in today’s markets.
China Biopharma: Hot Bed for Investments – Watch Now
In Part 2, Dr. Linda Pullan, Principal, Pullan Consulting, covers China investments, as well as advice for negotiating China deals.
China’s GMP Strategies: Dealing with Quality Management Issues – Watch Now
In Part 3, Fai Poon, President, QuaCell Biotech, Ltd., covers China regulatory issues, a review of current challenges in biopharma quality management in China, and opportunities for progress with growing CMO platforms and emerging CQO business.
Bioprocessing Challenges and CMO Opportunities – Watch Now
In Part 4, Dr. Scott Wheelwright, Co-Founder and Principal, Complya Asia, provides an overview of factors affecting manufacturing, manufacturing trends by market, biopharmaceutical manufacturing in China among CMOs and developing companies.